Antiviral agent-92
Antiviral agent-92 is an antiviral proliferation agent. Antiviral agent-92 blocks ESCRT recruitment by disrupting the interaction between the viral PTAP late domain and the TSG101 UEV domain, and disrupts the interaction of full-length TSG101 with HIV Gag and EBOV VP40, without cytotoxicity. Antiviral agent-92 reduces the replication of Ebola virus, Marburg virus, Nipah virus, and enterovirus. Antiviral agent-92 can be used in research related to viral infection.
For research use only. We do not sell to patients.
- Formula: C18H14N4O
- Molecular Weight:302.33
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antiviral agent-92 (10 μM; 6-36 h) reduces the interaction of TSG101 with HIV-1 Gag and EBOV VP40 in HEK293T cells while maintaining a high cell count[1].
Antiviral agent-92 (1-7 μM; 60 min-3 days) reduces EBOV titers in HEK293T and VeroE6 cells[1].
Antiviral agent-92 (1-5 μM; 60 min-3 days) reduces MARV and NiV titers in VeroE6 cells[1].
Antiviral agent-92 (10-30 μM; 1-8 h) reduces EV-D68 titers in HeLa R19 cells by approximately 2 log10 in lysates and 3 log10 in supernatants, but has no effect on HRV-B14[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:VeroE6 and HEK293T cells
-
Concentration:1, 5, 10, 20, 50, and 100 μM
-
Incubation Time:3 days
-
Result:Displayed acceptable toxicity levels in VeroE6 and HEK293T cells across 1-100 μM.
Chemical Information
-
Molecular Weight 302.33
-
Formula C18H14N4O
-
SMILES
OC1=CC=C2N=C(N/N=C/C3=CNC4=C3C=CC=C4)C=CC2=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)